How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer


HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.

Related Videos
Sue Friedman in an interview with CURE
Catrina Crutcher in an interview with CURE
Related Content